Key Record Dates
ClinicalTrials.gov Identifier: | NCT04847466 |
---|---|
Brief Title: | Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer |
First Submitted : | April 15, 2021 |
First Submitted that Met QC Criteria : | April 15, 2021 |
First Posted : | April 19, 2021 |
Last Update Submitted that Met QC Criteria : | February 11, 2023 |
Last Update Posted : | February 14, 2023 |